{"id":"a1e4c070-10f3-53da-8d3d-64c7915dff61","stable_key":"d39c4b36-9a88-5f52-8e6b-93a248dc4bfc:hericenones-erinacines-erinacine-a-glt1","predicate":"preserves","statement":"Erinacine A preserved GLT-1 and related glutamate-clearance machinery after experimental ischemia; the GLT-1 inhibitor WAY-213613 reversed protection in mixed cultures.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"617abffe-ea0c-5eae-8733-520d119ad4cf","mechanism_event_label":"Erinacine A preserved GLT-1 and related glutamate-clearance machinery after experimental ischemia; the GLT-1 inhibitor WAY-213613 reversed protection in mixed cultures.","subject":{"id":"0665d81c-c5d4-518b-82dd-a8338bb9ebc7","slug":"erinacine-a","display_name":"Erinacine A","entity_type_key":"small_molecule"},"object":{"id":"bc521983-3f83-5a06-9b6f-22572cc55f68","slug":"mouse-astrocytic-glutamate-clearance-machinery","display_name":"Mouse astrocytic GLT-1/GLAST/Kir4.1 glutamate-clearance machinery","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"617abffe-ea0c-5eae-8733-520d119ad4cf","stable_key":"d39c4b36-9a88-5f52-8e6b-93a248dc4bfc:hericenones-erinacines-erinacine-a-glt1-event","event_type":"observed_relationship","label":"Erinacine A preserved GLT-1 and related glutamate-clearance machinery after experimental ischemia; the GLT-1 inhibitor WAY-213613 reversed protection in mixed cultures.","description":"Erinacine A preserved GLT-1 and related glutamate-clearance machinery after experimental ischemia; the GLT-1 inhibitor WAY-213613 reversed protection in mixed cultures.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"0665d81c-c5d4-518b-82dd-a8338bb9ebc7","slug":"erinacine-a","display_name":"Erinacine A","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"bc521983-3f83-5a06-9b6f-22572cc55f68","slug":"mouse-astrocytic-glutamate-clearance-machinery","display_name":"Mouse astrocytic GLT-1/GLAST/Kir4.1 glutamate-clearance machinery","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"2da087df-a493-579d-ad12-23c9ca0efb1b","slug":"mouse-glt1","display_name":"Mouse glutamate transporter 1 / Slc1a2","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"528fe7c0-a944-5a3f-a05d-9e7776a3175e","slug":"way-213613","display_name":"WAY-213613 GLT-1 inhibitor","entity_type_key":"drug"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"dose","value_text":"Erinacine A; WAY-213613 inhibitor control","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"duration","value_text":"Seven-day pre-treatment plus three-day post-treatment in vivo","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_scope","value_text":"literature_reviewed; model-specific source-derived curation","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Mouse glia-neuron cultures and transient hypoxia-ischemia model","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The mixed pre/post route and mouse injury model do not establish human stroke treatment.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Hericenones & Erinacines chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings.","comparator":null,"unit":null,"notes":"","entity":{"slug":"hericenones-erinacines","display_name":"Hericenones and erinacines","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Mouse glia-neuron cultures and transient hypoxia-ischemia model","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Erinacine A preserved GLT-1 and related glutamate-clearance machinery after experimental ischemia; the GLT-1 inhibitor WAY-213613 reversed protection in mixed cultures.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Erinacine A attenuates glutamate transporter 1 downregulation and protects against ischemic brain injury. (2022). https://pubmed.ncbi.nlm.nih.gov/35882273/ DOI: 10.1016/j.lfs.2022.120833","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"In vitro and oral/intranasal mouse treatment","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"Glutamate transport, excitotoxicity and tissue injury","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"141fdb7b-4d3a-552c-b2a2-10e95bebfee2","evidence_kind":"source_excerpt","locator":"Lines 143-152","start_line":143,"end_line":152,"excerpt":"## hericenones-erinacines-erinacine-a-glt1\nErinacine A preserved GLT-1 and related glutamate-clearance machinery after experimental ischemia; the GLT-1 inhibitor WAY-213613 reversed protection in mixed cultures.\nModel/species: Mouse glia-neuron cultures and transient hypoxia-ischemia model\nTissue/system: Glutamate transport, excitotoxicity and tissue injury\nExposure: Erinacine A; WAY-213613 inhibitor control\nRoute: In vitro and oral/intranasal mouse treatment\nDuration: Seven-day pre-treatment plus three-day post-treatment in vivo\nLimits: The mixed pre/post route and mouse injury model do not establish human stroke treatment.\nPrimary reference: Erinacine A attenuates glutamate transporter 1 downregulation and protects against ischemic brain injury. (2022). https://pubmed.ncbi.nlm.nih.gov/35882273/ DOI: 10.1016/j.lfs.2022.120833\nAccess: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","model_system":"Mouse glia-neuron cultures and transient hypoxia-ischemia model","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Exact original curation span with primary citation; not a publisher quotation.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"aa7c09fd-ab4a-51ff-b463-d35547dc41ba","stable_key":"import-d39c4b36-9a88-5f52-8e6b-93a248dc4bfc","title":"Hericenones & Erinacines: mechanism of action and interactions (2026-09-20)","document_type":"imported_text","citation_label":"Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text.","file_path":"","sha256":"f1ff2966f222f5c463e8e509ec1b1642a0053cd38f121f3847cdd21855c46e85","revision_id":"d00076e0-da87-5100-92ed-0525190b25a1","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}